Your browser doesn't support javascript.
loading
The clinical effectiveness of using a predictive algorithm to guide antidepressant treatment in primary care (PReDicT): an open-label, randomised controlled trial.
Browning, Michael; Bilderbeck, Amy C; Dias, Rebecca; Dourish, Colin T; Kingslake, Jonathan; Deckert, Jürgen; Goodwin, Guy M; Gorwood, Philip; Guo, Boliang; Harmer, Catherine J; Morriss, Richard; Reif, Andreas; Ruhe, Henricus G; van Schaik, Anneke; Simon, Judit; Sola, Victor Perez; Veltman, Dick J; Elices, Matilde; Lever, Anne G; Menke, Andreas; Scanferla, Elisabetta; Stäblein, Michael; Dawson, Gerard R.
Afiliação
  • Browning M; P1vital Ltd, Howbery Park, Wallingford, UK. mbrowning@p1vital.com.
  • Bilderbeck AC; Department of Psychiatry, University of Oxford, Oxford, UK. mbrowning@p1vital.com.
  • Dias R; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK. mbrowning@p1vital.com.
  • Dourish CT; P1vital Ltd, Howbery Park, Wallingford, UK.
  • Kingslake J; P1vital Products Ltd, Howbery Park, Wallingford, UK.
  • Deckert J; P1vital Ltd, Howbery Park, Wallingford, UK.
  • Goodwin GM; P1vital Products Ltd, Howbery Park, Wallingford, UK.
  • Gorwood P; P1vital Products Ltd, Howbery Park, Wallingford, UK.
  • Guo B; Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, University Hospital of Würzburg, Würzburg, Germany.
  • Harmer CJ; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Morriss R; Université de Paris, Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Paris, France.
  • Reif A; GHU Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, Paris, France.
  • Ruhe HG; Division of Psychiatry and Applied Psychology, University of Nottingham, Nottingham, UK.
  • van Schaik A; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Simon J; Division of Psychiatry and Applied Psychology, University of Nottingham, Nottingham, UK.
  • Sola VP; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt - Goethe University, Frankfurt am Main, Germany.
  • Veltman DJ; Department of Psychiatry, Radboudumc, Nijmegen, Nijmegen, The Netherlands.
  • Elices M; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, The Netherlands.
  • Lever AG; Department of Psychiatry, Amsterdam Public Health Research Institute, Amsterdam UMC, Amsterdam, The Netherlands.
  • Menke A; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Scanferla E; Department of Health Economics, Center for Public Health, Medical University of Vienna, Vienna, Austria.
  • Stäblein M; Hospital del Mar Medical Research Institute, IMIM, Barcelona, Spain. Centro de Investigación Biomédica en Red (CIBERSAM), Madrid, Spain.
  • Dawson GR; Department of Psychiatry, Amsterdam UMC, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Neuropsychopharmacology ; 46(7): 1307-1314, 2021 06.
Article em En | MEDLINE | ID: mdl-33637837
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção Primária à Saúde / Antidepressivos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuropsychopharmacology Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Atenção Primária à Saúde / Antidepressivos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Neuropsychopharmacology Assunto da revista: NEUROLOGIA / PSICOFARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido